Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1.67M
-
Shares change
-
-114K
-
Total reported value, excl. options
-
$2.62M
-
Value change
-
-$179K
-
Number of buys
-
4
-
Number of sells
-
-8
-
Price
-
$1.57
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q1 2023
17 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q1 2023.
Journey Medical Corp - Common Stock (DERM) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.67M shares
of 17.2M outstanding shares and own 9.7% of the company stock.
Largest 10 shareholders include B. Riley Financial, Inc. (775K shares), PERKINS CAPITAL MANAGEMENT INC (218K shares), Nantahala Capital Management, LLC (212K shares), AMERICAN FINANCIAL GROUP INC (180K shares), NEUBERGER BERMAN GROUP LLC (129K shares), FIRST MANHATTAN CO. LLC. (35.3K shares), GEODE CAPITAL MANAGEMENT, LLC (29.5K shares), VANGUARD GROUP INC (21K shares), B. Riley Wealth Advisors, Inc. (17.3K shares), and Creative Planning (11.8K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.